Tomás Pulido

10.0k total citations · 4 hit papers
93 papers, 6.5k citations indexed

About

Tomás Pulido is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Tomás Pulido has authored 93 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Pulmonary and Respiratory Medicine, 54 papers in Cardiology and Cardiovascular Medicine and 16 papers in Genetics. Recurrent topics in Tomás Pulido's work include Pulmonary Hypertension Research and Treatments (80 papers), Cardiovascular Issues in Pregnancy (30 papers) and Vascular Anomalies and Treatments (16 papers). Tomás Pulido is often cited by papers focused on Pulmonary Hypertension Research and Treatments (80 papers), Cardiovascular Issues in Pregnancy (30 papers) and Vascular Anomalies and Treatments (16 papers). Tomás Pulido collaborates with scholars based in Mexico, Brazil and United States. Tomás Pulido's co-authors include Nazzareno Galiè, Lewis J. Rubin, Gérald Simonneau, Robyn J. Barst, Isabelle Leconte, Michael J. Landzberg, Adaani Frost, David B. Badesch, Carol M. Black and Sébastiên Roux and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Tomás Pulido

81 papers receiving 6.3k citations

Hit Papers

Bosentan Therapy for Pulmonary Arterial Hypertension 2002 2026 2010 2018 2002 2013 2018 2013 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bosentan Therapy for Pulmonary Arterial Hypertension
    2002 2.0k citations Lewis J. Rubin, Robyn J. Barst et al. profile →
  2. Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
    2013 948 citations Tomás Pulido, Richard N. Channick et al. profile →
  3. Risk stratification and medical therapy of pulmonary arterial hypertension
    2018 521 citations Nazzareno Galiè, Richard N. Channick et al. European Respiratory Journal profile →
  4. Pulmonary Arterial Hypertension
    2013 378 citations Michael D. McGoon, Raymond L. Benza et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomás Pulido Mexico 28 5.9k 4.2k 1.2k 785 676 93 6.5k
Seán Gaine Ireland 38 6.8k 1.2× 4.0k 1.0× 1.2k 1.0× 665 0.8× 917 1.4× 143 8.2k
Joanna Pepke‐Żaba United Kingdom 44 7.9k 1.4× 4.9k 1.2× 1.6k 1.3× 593 0.8× 552 0.8× 131 9.1k
Pavel Jansa Czechia 27 4.9k 0.8× 3.8k 0.9× 1.1k 1.0× 310 0.4× 426 0.6× 153 5.5k
Anna R. Hemnes United States 44 5.8k 1.0× 4.1k 1.0× 478 0.4× 728 0.9× 434 0.6× 222 7.2k
Kelly Chin United States 30 4.0k 0.7× 2.8k 0.7× 479 0.4× 569 0.7× 325 0.5× 137 4.9k
Carmine Dario Vizza Italy 34 3.8k 0.6× 3.2k 0.8× 495 0.4× 578 0.7× 322 0.5× 214 4.9k
Ivan M. Robbins United States 42 10.9k 1.9× 7.0k 1.7× 2.2k 1.8× 1.2k 1.5× 1.1k 1.7× 106 12.2k
Marcin Kurzyna Poland 25 3.5k 0.6× 2.8k 0.7× 626 0.5× 567 0.7× 254 0.4× 164 4.5k
Myung H. Park United States 22 3.1k 0.5× 2.9k 0.7× 471 0.4× 486 0.6× 229 0.3× 64 4.5k
James R. Klinger United States 36 3.6k 0.6× 2.3k 0.5× 443 0.4× 435 0.6× 246 0.4× 136 5.0k

Countries citing papers authored by Tomás Pulido

Since Specialization
Citations

This map shows the geographic impact of Tomás Pulido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomás Pulido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomás Pulido more than expected).

Fields of papers citing papers by Tomás Pulido

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomás Pulido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomás Pulido. The network helps show where Tomás Pulido may publish in the future.

Co-authorship network of co-authors of Tomás Pulido

This figure shows the co-authorship network connecting the top 25 collaborators of Tomás Pulido. A scholar is included among the top collaborators of Tomás Pulido based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomás Pulido. Tomás Pulido is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jerjes‐Sánchez, Carlos, Alicia Ramírez‐Rivera, Humberto García‐Aguilar, et al.. (2024). Demographic, hemodynamic characteristics, and therapeutic trends of pulmonary hypertension patients: The Pulmonary Hypertension Mexican registry (REMEHIP). Pulmonary Circulation. 14(2). e12395–e12395. 2 indexed citations
3.
Preston, Ioana R., Luke Howard, David Langleben, et al.. (2024). Management of pulmonary hypertension in special conditions. European Respiratory Journal. 64(4). 2401180–2401180. 6 indexed citations
4.
Orozco‐Levi, Mauricio, Rogério Souza, G. Meyer, et al.. (2024). Pathway to care, treatment and disease burden of pulmonary arterial hypertension: a real-world survey of physicians and patients in Latin America. BMJ Open. 14(12). e087263–e087263. 2 indexed citations
5.
Sierra, Alejandro de la, et al.. (2022). SPONTANEOUS CORONARY ARTERY DISSECTION IN A YOUNG PATIENT WITH ANTIPHOSPHOLIPID SYNDROME. Journal of the American College of Cardiology. 79(9). 2971–2971.
6.
Gatzoulis, Michael Α., Michael J. Landzberg, Maurice Beghetti, et al.. (2018). Evaluation of Macitentan in Patients With Eisenmenger Syndrome. Circulation. 139(1). 51–63. 78 indexed citations
7.
Benza, Raymond L., Mardi Gomberg‐Maitland, Teresa DeMarco, et al.. (2015). Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 192(11). 1345–1354. 72 indexed citations
8.
Jing, Zhi‐Cheng, Keyur Parikh, Tomás Pulido, et al.. (2013). Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension. Circulation. 127(5). 624–633. 242 indexed citations
9.
Sitbon, Olivier, Richard N. Channick, Marion Delcroix, et al.. (2013). Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH). European Respiratory Journal. 42(Suppl 57). P4060–P4060. 5 indexed citations
10.
Souza, Rogério, Richard N. Channick, Marion Delcroix, et al.. (2013). Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan. CHEST Journal. 144(4). 879A–879A. 1 indexed citations
11.
D’Armini, Andrea Maria, Hossein Ardeschir Ghofrani, Nick H. Kim, et al.. (2013). Riociguat for the treatment of inoperable CTEPH or persistent/recurrent PH after pulmonary endarterectomy (PEA): A responder analysis from the phase III CHEST-1 study. European Respiratory Journal. 42(Suppl 57). P2598–P2598. 1 indexed citations
12.
Jansa, Pavel, Richard N. Channick, Marion Delcroix, et al.. (2013). Impact of macitentan on the health-related quality of life (HRQoL) in pulmonary arterial hypertension (PAH): Results from a long-term randomised controlled trial. European Respiratory Journal. 42(Suppl 57). P4075–P4075. 2 indexed citations
13.
McGoon, Michael D., Raymond L. Benza, Pilar Escribano Subías, et al.. (2013). Pulmonary Arterial Hypertension. Journal of the American College of Cardiology. 62(25). D51–D59. 378 indexed citations breakdown →
14.
Barst, Robyn J., D. Dunbar Ivy, Guillermo Gaitan, et al.. (2011). A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension. Circulation. 125(2). 324–334. 266 indexed citations
15.
Lupi‐Herrera, Eulo, et al.. (2010). Interpretación de la relación presión-flujo en la hipertensión arterial pulmonar idiopática. Revista Portuguesa de Pneumologia. 80(3). 163–173.
16.
Lupi‐Herrera, Eulo, et al.. (2009). [Clinical interpretation for the pressure-flow relationships in extrinsic allergic alveolitis and in interstitial lung disease pulmonary hypertension patients. Should we care for the lung, the pulmonary artery pressure or both?].. PubMed. 79(2). 91–103.
17.
Pulido, Tomás, et al.. (2009). Interaction of acenocoumarol and sitaxentan in pulmonary arterial hypertension. European Journal of Clinical Investigation. 39(s2). 14–18. 7 indexed citations
18.
Rosas-Peralta, Martín, Julio Sandoval, Fause Attié, et al.. (2006). Implicaciones clínicas y pronósticas del estudio circadiano de la modulación simpático-vagal de la variabilidad de la frecuencia cardiaca en pacientes con hipertensión arterial pulmonar grave. Gaceta Médica de México. 142(1). 19–28. 9 indexed citations
19.
González, José Javier Elizalde, Julio Sandoval, Alicia Ramírez‐Rivera, et al.. (2004). Diagnóstico, estratificación y tratamiento de la tromboembolia pulmonar aguda. Guías y Recomendaciones del Capítulo de Circulación Pulmonar de la Sociedad Mexicana de Cardiología. Revista Portuguesa de Pneumologia. 74. 547–585. 2 indexed citations
20.
Sandoval, Julio, et al.. (2001). Nocturnal Oxygen Therapy in Patients with the Eisenmenger Syndrome. American Journal of Respiratory and Critical Care Medicine. 164(9). 1682–1687. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seán Gaine Breakdown of academic impact, for papers by Joanna Pepke‐Żaba Breakdown of academic impact, for papers by Pavel Jansa Breakdown of academic impact, for papers by Anna R. Hemnes Breakdown of academic impact, for papers by Kelly Chin Breakdown of academic impact, for papers by Carmine Dario Vizza Breakdown of academic impact, for papers by Ivan M. Robbins Breakdown of academic impact, for papers by Marcin Kurzyna Breakdown of academic impact, for papers by Myung H. Park Breakdown of academic impact, for papers by James R. Klinger
Rankless by CCL
2026